A detailed history of Knott David M Jr transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Knott David M Jr holds 2,000 shares of VRTX stock, worth $816,360. This represents 0.33% of its overall portfolio holdings.

Number of Shares
2,000
Previous 3,000 33.33%
Holding current value
$816,360
Previous $1.41 Million 33.85%
% of portfolio
0.33%
Previous 0.56%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$460.0 - $505.78 $460,000 - $505,780
-1,000 Reduced 33.33%
2,000 $930,000
Q2 2023

Aug 11, 2023

SELL
$314.42 - $351.91 $1.26 Million - $1.41 Million
-4,000 Reduced 57.14%
3,000 $1.06 Million
Q1 2023

May 11, 2023

SELL
$283.23 - $323.1 $283,230 - $323,100
-1,000 Reduced 12.5%
7,000 $2.21 Million
Q4 2022

Feb 13, 2023

SELL
$285.76 - $321.48 $2.57 Million - $2.89 Million
-9,000 Reduced 52.94%
8,000 $2.31 Million
Q4 2021

Feb 11, 2022

BUY
$177.01 - $223.45 $3.01 Million - $3.8 Million
17,000 New
17,000 $3.73 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Knott David M Jr Portfolio

Follow Knott David M Jr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

News

Stay updated on Knott David M Jr with notifications on news.